Témata:
- Is it time for a new taxane?
- Maintenance therapy
- Screen everyone for EGFR mutations?
- Appropriate setting for EGFR TKIs
- EGFR TKI’s – only for mutation patients?
- Surgery for stage IIIa patients with lung cancer
- Is two cycles of chemoradiation enough?
Registrace
- Zlevněná registrace do 14. března 2011
- Běžná registrace do 28. dubna 2011
- Online registrace
Moderator: Ramaswamy Govindan, MD
8:00 am
Welcome and introduction
Ramaswamy Govindan, MD
8:05 am
Is it time for a new taxane?
Yes
Suresh S. Ramalingam, MD
No
Primo Lara, MD
8:50 am
Maintenance therapy
Yes
Alan B. Sandler, MD
No
Speaker invited
9:35 am
Screen everyone with metastatic NSCLC for EGFR mutations?
Yes
Anne S. Tsao, MD
No
Heather A. Wakelee, MD
10:20 am
Break
10:40 am
Appropriate setting for EGFR TKIs Frontline/maintenance
Alan B. Sandler, MD
Second line and beyond
Suresh S. Ramalingam, MD
11:25 am
EGFR TKIs Only for mutation patients
Primo Lara, MD
No, for everyone
Karen L. Kelly, MD
12:10 pm
Lunch
1:00 pm
Surgery for stage IIIa patients with lung cancer
Sometimes
Anne S. Tsao, MD
Never
Speaker invited
1:45 pm
Two cycles of chemoradiation 2 cycles is enough
Heather A. Wakelee, MD
2 cycles is not enough
Karen L. Kelly, MD
2:30
Closing notes and adjourn
Kontakt: meetings@imedex.com
Web: http://www.imedex....ements/a254-01.asp
- Přidat do kalendáře: 2011-05-07 00:00:00 2011-05-07 23:59:59 Europe/Prague Great Debates & Updates in Thoracic Malignancies Témata: Is it time for a new taxane? Maintenance therapy Screen everyone for EGFR mutations? Appropriate setting for EGFR TKIs EGFR TKI’s – only for mutation patients? Surgery for stage IIIa patients with lung cancer Is two cycles of chemoradiation enough? Sheraton Fishermans Wharf Hotel, San Francisco, California, USA
